HEALTHSTREAM INC
For the period ended Mar 31, 2024. Filed Apr 25, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 25, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of the 2023 Form 10-K.
On September 13, 2023, the Company announced a share repurchase program approved by the Company’s Board under which the Company was authorized to purchase up to $10.0 million of its common stock. During the term of this program, the Company repurchased 404,188 shares under this program at an aggregate fair value of $8.9 million, reflecting an average price per share of $22.07 (excluding the cost of broker commissions). The share repurchase program expired according to its term on March 31, 2024.
The table below sets forth activity under the stock repurchase plan for the three months ended March 31, 2024.
| Period | (a) Total number of shares (or units) purchased | (b) Average price paid per share (or unit)(1) | (c) Total number of shares (or units) purchased as part of publicly announced plans or programs | (d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs |
|---|---|---|---|---|
| Month #1 (January 1 - January 31) | — | $— | — | $1,079,336 |
| Month #2 (February 1 - February 29) | — | — | — | 1,079,336 |
| Month #3 (March 1 - March 31) | — | — | — | — |
| Total | — | $— | — | $— |
Item5. Other Information
None. Without limiting the generality of the foregoing, during thethree months ended* March 31, 2024,*no director or officer of the Company adopted or terminated any “Rule10b5-1 trading arrangement,” or any “non-Rule10b-5 trading arrangement,” as such terms are defined in Item408 of Regulation S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.